Polish researchers publish new study showing highly positive results with G-CSF treatment for DMD.
This groundbreaking 2015 discovery explains how the understanding of the mechanism of DMD is changing, and how DMD is more closely linked to muscle stem cell missignalling than prior understanding of the disease.
Granulocyte-colony stimulating factor, often given prior to stem cell transplants to mobilize stem cells, is now being studied as a potential low-dose long-term complentary therapy to stem cell therapy.
This flagship study from Neurogen Brain and Spine Institute, conducted by Dr. Alok Sharma, is perhaps the most extensive stem cell study yet undertaken for Duchenne. Dr. Sharma has since succesfully treated over 400 DMD patients with stem cell therapy and is currently conducting another stem cell-DMD clinical trial.
French researchers studied the effects of autologous myyoblast stem cell therapy on 12 OPMD patients with positive functional improvements over 2 years.
This study examines the potential role stem cell therapy has in healing damaged heart muscles in DMD.
Muscle stem cells are used for DMD.